Lista de obras - Judith R Kroep - Dominio Público Uruguay

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer.

artículo científico publicado en 2015

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.

artículo científico publicado en 2015

A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.

artículo científico publicado en 2016

Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer.

artículo científico publicado en 2014

Actively personalized vaccination trial for newly diagnosed glioblastoma

scientific article published on 19 December 2018

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01).

artículo científico publicado en 2014

Adherence and patients' experiences with the use of oral anticancer agents.

artículo científico publicado en 2013

Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.

artículo científico

Advances in epithelial ovarian cancer therapy.

artículo científico publicado en 2012

Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies.

artículo científico publicado en 2017

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.

artículo científico publicado en 2010

Breast cancer specialists' views on and use of risk prediction models in clinical practice: a mixed methods approach

artículo científico publicado en 2014

CDK4/6 inhibition in early and metastatic breast cancer: A review.

artículo científico publicado en 2017

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

artículo científico publicado en 2013

Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment ⬇️

artículo científico publicado el 22 de febrero de 2013

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer

artículo científico publicado en 2017

Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan.

artículo científico publicado en 2017

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach

artículo científico publicado en 2012

Development of a Decision Aid about fertility preservation for women with breast cancer in The Netherlands

artículo científico publicado en 2013

Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines.

artículo científico publicado en 2000

Diflomotecan, a promising homocamptothecin for cancer therapy

scientific article published on 01 January 2009

Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer.

artículo científico publicado en 2016

Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer.

scientific article published on 21 December 2010

Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial

artículo científico publicado en 2015

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation.

artículo científico publicado en 2010

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials ⬇️

artículo científico publicado en 2015

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.

artículo científico publicado en 2011

Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients – A phase II trial

artículo científico publicado en 2014

Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach

artículo científico publicado en 2015

Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia.

artículo científico publicado en 2015

Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver

artículo científico publicado en 2003

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

artículo científico publicado en 2017

Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: current and future evidence.

artículo científico publicado en 2015

Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature.

artículo científico publicado en 2008

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

artículo científico publicado en 2020

Feasibility of tailored follow-up for patients with early breast cancer

artículo científico publicado en 2014

Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer

scientific article published on 01 July 1999

Gemcitabine-cisplatin: a schedule finding study.

artículo científico publicado en 1999

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

artículo científico publicado en 2018

Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study

artículo científico publicado en 2020

Illness Perceptions in Women with Breast Cancer—a Systematic Literature Review

artículo científico publicado en 2015

Illness perceptions and quality of life in Japanese and Dutch women with breast cancer.

artículo científico publicado en 2013

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.

artículo científico publicado en 2017

Importance of patient reported outcome measures versus clinical outcomes for breast cancer patients evaluation on quality of care

artículo científico publicado en 2016

Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

artículo científico publicado en 2014

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy

artículo científico publicado en 2014

In reply

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

artículo científico publicado en 2016

Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.

artículo científico publicado en 2014

Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer.

artículo científico

Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer.

artículo científico publicado en 2010

Lifetime Transfusion Burden and Transfusion-Related Iron Overload in Adult Survivors of Solid Malignancies

scientific article published on 27 August 2019

Mechanisms of synergism between gemcitabine and cisplatin

artículo científico publicado en 1998

Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

artículo científico publicado en 2015

Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma

artículo científico publicado en 2014

Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: a systematic review.

artículo científico

No evidence of gemcitabine accumulation during weekly administration.

artículo científico publicado en 2005

Oncologist, patient, and companion questions during pretreatment consultations about adjuvant cancer treatment: a shared decision-making perspective

artículo científico publicado en 2016

Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer

artículo científico publicado en 2014

Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).

artículo científico publicado en 2018

Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure

artículo científico publicado en 2017

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial

scientific article published on 01 December 2014

Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors

scientific article published on 01 April 1999

Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer.

artículo científico publicado en 2006

Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer.

artículo científico publicado en 2004

Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods

artículo científico publicado en 2003

Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.

artículo científico publicado en 2002

Primary Ewing sarcoma of the iris.

artículo científico publicado en 2013

Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854).

artículo científico publicado en 2013

Psychosocial determinants of adherence with oral anticancer treatment: 'we don't need no education'

artículo científico publicado en 2020

Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma

scientific article published on 01 February 2019

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach

artículo científico publicado en 2015

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial

scientific article published on 11 November 2020

Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer.

artículo científico publicado en 2013

Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity.

artículo científico publicado en 2004

RE: Serum vit D levels and response to molecular subtypes in breast cancer

artículo científico publicado en 2016

Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.

artículo científico publicado en 2015

Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer

artículo científico publicado en 2017

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.

artículo científico publicado en 2012

Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC)

artículo científico publicado en 1998

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

artículo científico

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers

artículo científico publicado en 2015

Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines.

artículo científico publicado en 2000

Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy

artículo científico publicado en 2017

Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04).

artículo científico publicado en 2016

Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

scientific article published on 01 March 2020

Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.

artículo científico publicado en 2007

Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics.

artículo científico publicado en 2014

Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe.

artículo científico publicado en 2017

The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review.

artículo científico publicado en 2017

The clinical approach toward giant cell tumor of bone

artículo científico publicado en 2014

The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis.

artículo científico publicado en 2016

The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

artículo científico publicado en 2015

The iontophoresis of fentanyl citrate in humans.

artículo científico publicado en 1995

The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis).

artículo científico publicado en 2012

The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy

artículo científico

The role of bevacizumab in advanced epithelial ovarian cancer.

artículo científico publicado en 2012

The role of deoxycytidine kinase in gemcitabine cytotoxicity

artículo científico publicado en 2000

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).

artículo científico publicado en 2015

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma

artículo científico publicado en 2020

Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision making

artículo científico publicado en 2016

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

artículo científico publicado en 2016

Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study

artículo científico publicado en 2014

Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01).

artículo científico publicado en 2015

We're in this together: Patients', caregivers' and health care providers' illness perceptions about non-small-cell lung cancer (NSCLC).

artículo científico publicado en 2015

[Adjuvant cancer treatment: what benefit does the patient consider worthwhile?]

scientific article published on 01 January 2011

[Antitumour effects of bisphosphonates in breast cancer]

artículo científico publicado en 2010

[Fertility preservation in female oncology patients]

scientific article published on 01 November 2008

[Long-term beneficial effects of cetuximab in a woman with metastasised rectal carcinoma without expression of the epidermal growth factor receptor]

artículo científico publicado en 2006

[Pregnancy-associated breast cancer: current opinions on diagnosis and treatment]

[Three patients with autoimmune hepatitis: the importance of early diagnosis and remission]

artículo científico publicado en 2005

Lista de obras de Judith R Kroep

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer.

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.

A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.

Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer.

Actively personalized vaccination trial for newly diagnosed glioblastoma

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01).

Adherence and patients' experiences with the use of oral anticancer agents.

Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.

Advances in epithelial ovarian cancer therapy.

Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies.

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.

Breast cancer specialists' views on and use of risk prediction models in clinical practice: a mixed methods approach

CDK4/6 inhibition in early and metastatic breast cancer: A review.

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment ⬇️

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer

Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan.

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach

Development of a Decision Aid about fertility preservation for women with breast cancer in The Netherlands

Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines.

Diflomotecan, a promising homocamptothecin for cancer therapy

Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer.

Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer.

Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation.

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials ⬇️

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.

Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients – A phase II trial

Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach

Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia.

Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: current and future evidence.

Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature.

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

Feasibility of tailored follow-up for patients with early breast cancer

Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer

Gemcitabine-cisplatin: a schedule finding study.

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study

Illness Perceptions in Women with Breast Cancer—a Systematic Literature Review

Illness perceptions and quality of life in Japanese and Dutch women with breast cancer.

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.

Importance of patient reported outcome measures versus clinical outcomes for breast cancer patients evaluation on quality of care

Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy

In reply

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.

Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer.

Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer.

Lifetime Transfusion Burden and Transfusion-Related Iron Overload in Adult Survivors of Solid Malignancies

Mechanisms of synergism between gemcitabine and cisplatin

Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma

Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: a systematic review.

No evidence of gemcitabine accumulation during weekly administration.

Oncologist, patient, and companion questions during pretreatment consultations about adjuvant cancer treatment: a shared decision-making perspective

Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer

Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).

Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial

Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors

Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer.

Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer.

Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods

Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.

Primary Ewing sarcoma of the iris.

Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854).

Psychosocial determinants of adherence with oral anticancer treatment: 'we don't need no education'

Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial

Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer.

Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity.

RE: Serum vit D levels and response to molecular subtypes in breast cancer

Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.

Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.